Tate & Lyle joins forces with Solvay on digestive ingredient

Solactis Galactofructose is a non-digestible carbohydrate derived from milk. Following comprehensive clinical trials, it has been shown to deliver wide ranging health benefits as a prebiotic ingredient which also regulates digestive transit at very low dosages. Scientific results also suggest that it could be beneficial in stimulating mineral absorption, and helpful in managing weight.

Tate & Lyle and Solvay will use Solactis Galactofructose to create a range of ‘better for you’ food applications for and with customers.

Galactofructose was first employed as a food ingredient for infant milk formulas in the 1950s, and since the 1960s, it has been used in the pharmaceutical industry in North America, Asia and Europe. It’s supported by more than 50 years of scientific research, 30 of them conducted by Solvay, an international chemical and pharmaceutical group. The ingredient also holds a long history of use in Asia, where it has been employed in dairy applications and in infant nutrition.